Gauthereau-Torres, M.Y.; MartÃnez-Guillen, J.S.; Cervantes-Durán, C.; Gutiérrez-GarcÃa, C.J.; GodÃnez-Hernández, D.; Aguilera Méndez, A.; Ortega-Varela, L.F.
Preclinical Assessment of a Metformin–Melatonin Combination: Antinociceptive Synergism. Pharmaceutics 2025, 17, 1057.
https://doi.org/10.3390/pharmaceutics17081057
AMA Style
Gauthereau-Torres MY, MartÃnez-Guillen JS, Cervantes-Durán C, Gutiérrez-GarcÃa CJ, GodÃnez-Hernández D, Aguilera Méndez A, Ortega-Varela LF.
Preclinical Assessment of a Metformin–Melatonin Combination: Antinociceptive Synergism. Pharmaceutics. 2025; 17(8):1057.
https://doi.org/10.3390/pharmaceutics17081057
Chicago/Turabian Style
Gauthereau-Torres, Marcia Yvette, Jenny Selene MartÃnez-Guillen, Claudia Cervantes-Durán, Carmen Judith Gutiérrez-GarcÃa, Daniel GodÃnez-Hernández, Asdrúbal Aguilera Méndez, and Luis Fernando Ortega-Varela.
2025. "Preclinical Assessment of a Metformin–Melatonin Combination: Antinociceptive Synergism" Pharmaceutics 17, no. 8: 1057.
https://doi.org/10.3390/pharmaceutics17081057
APA Style
Gauthereau-Torres, M. Y., MartÃnez-Guillen, J. S., Cervantes-Durán, C., Gutiérrez-GarcÃa, C. J., GodÃnez-Hernández, D., Aguilera Méndez, A., & Ortega-Varela, L. F.
(2025). Preclinical Assessment of a Metformin–Melatonin Combination: Antinociceptive Synergism. Pharmaceutics, 17(8), 1057.
https://doi.org/10.3390/pharmaceutics17081057